retatrutide triple receptor agonist Lilly's agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial Retatrutide Half Life: A Doctor

Currently, there is no clinical research confirming that microdoses of tirzepatide can cause weight loss, improve glycemic control, or enhance metabolic health

Scott Keatley, R.D., of Keatley Medical Nutrition Therapy

But theres evidence it influences how your body processes caffeine, potentially moderating some of the cardiovascular stress that comes with high-caffeine intake

Conversely, a few studies reported high levels of vitamin B12 in the blood of patients with a worse COVID-19 outcome 48,49 potentially due to cytolysis leading to the release of intracellular B12 into the plasma and disrupted B12 clearance by the liver, which is often affected in these patients 50

Our experienced team is here to support you every step of the way, including helping you manage any side effects you may experience during your first week on the medication